Loading...
Preliminary evidence suggests that the macrolide antibiotic troleandomycin prolongs the serum half-life of methylprednisolone, possibly allowing dose reductions of the steroid and reducing side effects. This double-blind trial evaluated the long-term effects of adding troleandomycin to oral methylprednisolone.
The study randomized 75 severely asthmatic adults taking an average of about 31 mg of methylprednisolone daily to receive either troleandomycin (250 mg daily) or placebo. Clinicians then attempted to taper the steroid dose.
Fifty-seven patients completed 1 year of study; almost all patients in both groups had achieved alternate-day dosing of steroids. Average steroid doses and control of asthma did not differ between groups at either 1 …